What is the diagnosis and recommended treatment for a patient with impaired glucose regulation, normal renal function, and slightly elevated anion gap and monocyte percentage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Interpretation and Clinical Assessment

Based on these laboratory values, this patient does not have diabetic ketoacidosis or any acute hyperglycemic crisis requiring immediate intervention. The mildly elevated anion gap of 15 mEq/L with normal bicarbonate (19 mEq/L) and fasting glucose of 107 mg/dL indicates impaired fasting glucose (prediabetes) rather than diabetes or a metabolic emergency 1, 2.

Key Laboratory Findings Analysis

Normal Anion Gap Context:

  • The anion gap of 15 mEq/L is only minimally elevated above the modern reference range of 3-11 mmol/L (using ion-selective electrode methods), but this mild elevation with a normal bicarbonate of 19 mEq/L does not indicate metabolic acidosis 3, 4.
  • The bicarbonate of 19 mEq/L is just below the lower limit of normal (22-28 mEq/L) but remains well above the threshold for metabolic acidosis (bicarbonate <18 mEq/L would be required for DKA diagnosis) 1, 5.
  • An anion gap exceeding 24 mmol/L would be necessary to strongly suggest metabolic acidosis; values of 13-20 mmol/L are common in hospitalized patients without acidosis 3.

Glucose Status:

  • The fasting glucose of 107 mg/dL meets criteria for impaired fasting glucose (IFG), defined as 100-125 mg/dL 1, 2, 6.
  • This does NOT meet criteria for diabetes mellitus, which requires fasting plasma glucose ≥126 mg/dL 1, 6.
  • IFG represents an intermediate stage in the natural history of diabetes, with 10-15% of U.S. adults affected 2.

Other Laboratory Values:

  • The elevated monocyte percentage (13.4%, reference <12%) is a minor finding that can occur with chronic inflammation, infection, or stress, but is nonspecific and does not alter the primary diagnosis [@general medicine knowledge@].
  • Normal renal function (creatinine 0.60, eGFR 82.61) rules out uremic acidosis as a cause of the anion gap 4.
  • Normal hemoglobin (12.6 g/dL) and other CBC parameters indicate no significant anemia or hematologic abnormality [@general medicine knowledge@].

Primary Diagnosis

Impaired Fasting Glucose (Prediabetes) 1, 2, 6

This patient has impaired glucose regulation, not diabetes. The diagnosis is based on:

  • Fasting plasma glucose 100-125 mg/dL (patient has 107 mg/dL) 1, 2.
  • No evidence of diabetic ketoacidosis (would require glucose >250 mg/dL, bicarbonate <18 mEq/L, anion gap >10 mEq/L with positive ketones) 1, 5, 7.
  • No evidence of hyperosmolar hyperglycemic state (would require glucose >600 mg/dL, osmolality >320 mOsm/kg) 1.

Recommended Management for Impaired Fasting Glucose

Lifestyle Intervention (First-Line, Most Effective):

  • Patients with IFG should be counseled to lose 5-7% of their body weight through caloric restriction 2.
  • Engage in moderate physical activity for at least 150 minutes per week 1, 2.
  • Lifestyle modifications are more effective than pharmacologic therapy in preventing progression to diabetes 2.

Risk Factor Assessment: The following risk factors should be evaluated to stratify diabetes risk 2, 6:

  • Family history of diabetes
  • Body mass index >25 kg/m²
  • Sedentary lifestyle
  • Hypertension
  • Dyslipidemia
  • History of gestational diabetes
  • Polycystic ovary syndrome
  • Ethnicity (Black, Latin American, Native American, Asian-Pacific Islander)

Pharmacologic Therapy (Secondary Option):

  • Metformin or acarbose can delay or prevent onset of diabetes in patients with IFG, but medications are less effective than lifestyle changes 2.
  • The cost-effectiveness of pharmacologic therapy for IFG is uncertain 2.
  • Consider pharmacologic therapy only if lifestyle modifications fail and multiple risk factors are present 2.

Monitoring and Follow-Up:

  • Repeat fasting plasma glucose testing every 3 years if results remain in the IFG range 6.
  • Consider annual screening if multiple risk factors are present 6.
  • If fasting glucose reaches ≥126 mg/dL on two separate occasions, diabetes diagnosis is confirmed and requires more intensive management 1, 6.

Addressing the Mildly Elevated Anion Gap

No Acute Intervention Required:

  • The anion gap of 15 mEq/L with normal bicarbonate does not represent a metabolic emergency 3, 4.
  • Common causes of mild anion gap elevation in non-acidotic patients include hypertensive disease, chronic conditions, and laboratory variation 3.
  • If the anion gap were >24 mmol/L or if bicarbonate were <18 mEq/L, further investigation for metabolic acidosis would be warranted 3, 4.

Clinical Pitfall to Avoid:

  • Do not diagnose diabetic ketoacidosis based solely on a mildly elevated anion gap without confirming metabolic acidosis (pH <7.3, bicarbonate <18 mEq/L) and hyperglycemia (glucose >250 mg/dL) 1, 5, 7.
  • While DKA can rarely present with normal anion gap, this patient lacks all other diagnostic criteria for DKA 8.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Impaired glucose tolerance and impaired fasting glucose.

American family physician, 2004

Research

Update on value of the anion gap in clinical diagnosis and laboratory evaluation.

Clinica chimica acta; international journal of clinical chemistry, 2001

Research

Approach to Patients With High Anion Gap Metabolic Acidosis: Core Curriculum 2021.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2021

Guideline

Diabetic Ketoacidosis Diagnostic Criteria and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Diabetes Mellitus: Screening and Diagnosis.

American family physician, 2016

Guideline

Diagnostic Criteria and Management of Diabetic Ketoacidosis (DKA)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diabetic ketoacidosis presenting with a normal anion gap.

The American journal of medicine, 1986

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.